Evidence map›Paper›PMID 41536568›Full record

ArticleClinical kidney journal2026

Changing microbiology and outcomes of PD-associated peritonitis over four decades.

Leonie Kraft, Julia Oppold, Daniel Kitterer, Niko Braun, Martin Kimmel, Laura Twardowski, Dagmar Biegger, Tina Oberacker, Andrea Schwab, Silke Merz and 9 more

Abstract read
In one paragraph

Article in Clinical kidney journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Leonie KraftDepartment of General Internal Medicine and Nephrology, Robert Bosch Hospital Stuttgart, Stuttgart, Germany.ORCID https://orcid.org/0000-0002-5821-893X
Julia OppoldGerman Cancer Research Center, University of Heidelberg, Heidelberg, Germany.
Daniel KittererStuttgart-Vaihingen Kidney Center, Stuttgart, Germany.
Niko BraunInternal Nephrology Center Stuttgart-Mitte, Stuttgart, Germany.
Martin KimmelDepartment of Internal Medicine, Division of Nephrology, Hypertension and Autoimmune Disorders, Alb-Fils Kliniken, Göppingen, Germany.
Laura TwardowskiDepartment for Microbiology, Robert Bosch Hospital, Stuttgart, Germany.
Dagmar BieggerDr Margarete Fischer-Bosch-Institute of Clinical Pharmacology and University of Tuebingen, Stuttgart, Germany.
Tina OberackerDr Margarete Fischer-Bosch-Institute of Clinical Pharmacology and University of Tuebingen, Stuttgart, Germany.
Andrea SchwabDepartment of General Internal Medicine and Nephrology, Robert Bosch Hospital Stuttgart, Stuttgart, Germany.
Silke MerzDepartment of General Internal Medicine and Nephrology, Robert Bosch Hospital Stuttgart, Stuttgart, Germany.
Katharina WirkusCenter for Anesthesia and Intensive Care Medicine, Boeblingen clinics, Boeblingen, Germany.
Kevin SchulteDepartment of Nephrology and Hypertension, University Hospital Schleswig-Holstein-Campus Kiel, Kiel, Germany.
Roland SchmittDepartment of Nephrology and Hypertension, University Hospital Schleswig-Holstein-Campus Kiel, Kiel, Germany.
Jan T KielsteinDepartment of Nephrology, Rheumatology, Blood Purification, Academic Teaching Hospital Braunschweig, Braunschweig, Germany.
Gabriele EdenDepartment of Nephrology, Rheumatology, Blood Purification, Academic Teaching Hospital Braunschweig, Braunschweig, Germany.
Nico SchmidCenter for Medical Data Integration, Bosch Health Campus, Stuttgart, Germany.
Severin SchrickerDepartment of General Internal Medicine and Nephrology, Robert Bosch Hospital Stuttgart, Stuttgart, Germany.ORCID https://orcid.org/0000-0002-6770-3056
Joerg LatusDepartment of General Internal Medicine and Nephrology, Robert Bosch Hospital Stuttgart, Stuttgart, Germany.
Moritz SchanzDepartment of General Internal Medicine and Nephrology, Robert Bosch Hospital Stuttgart, Stuttgart, Germany.ORCID https://orcid.org/0000-0001-7300-8132

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Peritoneal dialysis (PD)-associated peritonitis remains a major complication affecting patient outcomes and modality survival. This study aims to evaluate temporal trends in pathogen distribution and antibiotic susceptibility over four decades as well as clinical outcomes in PD-associated peritonitis. Methods: We retrospectively analyzed 832 peritonitis cultures of PD patients across four decades from 1979 to 2024 treated at Robert Bosch Hospital, Stuttgart (Germany). For longitudinal comparison of pathogen distribution and antibiotic susceptibility, the study period was divided into four time periods: P1 (1979-1992), P2 (1993-2003), P3 (2004-2014), and P4 (2015-2024). Clinical response and outcomes were assessed in P4. Results: Gram-positive bacteria was the most frequent causative organisms (56%), followed by Gram-negative bacteria (30%) and culture-negative peritonitis (CNP, 13%). Gram-negative peritonitis increased significantly in P4 compared to P1-P3, while coagulase-negative staphylococci (CNS) declined from 31% in P1 to 14% in P4 ( Conclusion: Our findings show temporal changes of microbiological spectrum of PD-associated peritonitis over four decades. Polymicrobial and Gram-negative peritonitis were associated with poorer outcomes, emphasizing the need for ongoing microbiological surveillance and antibiotic stewardship to optimize PD care.

Indexed as

clinical responselong-term observationmicrobiological patternperitoneal dialysisperitonitis

Identifiers

PMID41536568
PMCPMC12798722

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.